Drug Shortage Report for AZARGA

Last updated on 2020-04-17 History
Report ID 105259
Drug Identification Number 02331624
Brand name AZARGA
Common or Proper name AZARGA OPH SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL BRINZOLAMIDE
Strength(s) 0.5% 1.0%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-02-17
Actual start date
Estimated end date 2020-04-02
Actual end date 2020-04-03
Shortage status Resolved
Updated date 2020-04-17
Company comments Limited quantity available for shipping
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-04-17 French Compare
v4 2020-04-17 English Compare
v3 2020-02-18 English Compare
v2 2020-02-04 French Compare
v1 2020-02-04 English Compare